{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-052104","form_type":"8-K","ticker":"INGR","cik":"0001046257","company_name":"Ingredion Inc","filed_at":"2026-08-04T10:09:26+00:00","discovered_at":"2026-08-04T10:10:02.144339+00:00","generated_at":"2026-08-04T10:10:12.164025+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Ingredion Q2 adjusted EPS $2.82, reaffirms guidance; Tate & Lyle acquisition approved","bullets":["Q2 reported EPS $1.78, adjusted EPS $2.82; reported operating income down 31%, adjusted down 5% vs Q2 2025.","Reaffirming full-year guidance: reported EPS $9.15-$9.75, adjusted EPS $10.30-$10.90.","Texture & Healthful Solutions delivered 9th consecutive quarter of net sales volume growth.","Ingredion's 595 pence all-cash offer for Tate & Lyle accepted by their shareholders on July 28.","Argo plant operating at normal production rates across all major units after reliability improvements."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-052104","json":"https://secwatch.observer/filing/0001628280-26-052104.json","markdown":"https://secwatch.observer/filing/0001628280-26-052104.md","text":"https://secwatch.observer/filing/0001628280-26-052104.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1046257/000162828026052104/0001628280-26-052104-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1046257/000162828026052104/ingr-20260804.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-04T10:10:12.164025+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}